US equity / EOD
Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Last close$1164.89
Daily change+1.04%
Market cap$1038.3B
IndustryPHARMACEUTICAL PREPARATIONS
30-day price history
Low 1,115.7High 1,280.34
End-of-day historical bars are adjusted according to the provider response and may be delayed.
This is general market information, not investment advice.